Clonal expansion of DNMT3A-mutant hematopoietic stem cells is a risk factor for myeloid malignancies and other morbidities. A new study uses multi-modal single-cell genomics to characterize the myeloid differentiation bias of DNMT3A-mutated clones, and finds preferential hypomethylation of binding motifs for key transcriptional regulators.
References
Liggett, L. A. & Sankaran, V. G. Cell 182, 1384–1400 (2020).
Fabre, M. A. et al. Nature 606, 335–342 (2022).
Koya, J. et al. Nat. Commun. 7, 10924 (2016).
Challen, G. A. et al. Nat. Genet. 44, 23–31 (2011).
Nam, A. S. et al. Nat. Genet. https://doi.org/.1038/s41588-022-01179-9 (2022).
Nam, A. S. et al. Nature 571, 355–360 (2019).
Ludwig, L. S. et al. Cell 176, 1325–1339.e22 (2019).
Xu, J. et al. eLife https://doi.org/10.7554/eLife.45105.001 (2019).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
V.G.S. serves as an advisor to and/or has equity in Branch Biosciences, Ensoma, Novartis, Forma and Cellarity, all unrelated to the present work. The authors have no other competing interests to declare.
Rights and permissions
About this article
Cite this article
Voit, R.A., Sankaran, V.G. Multi-omics on our multitudes. Nat Genet 54, 1449–1450 (2022). https://doi.org/10.1038/s41588-022-01175-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41588-022-01175-z
- Springer Nature America, Inc.